Yi Tang Selected Research

Apolipoproteins

12/2021	Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
12/2020	The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease.
6/2019	ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus.
1/2015	Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Tang Research Topics

Disease

91	Neoplasms (Cancer) 04/2024 - 03/2001
36	Infections 01/2024 - 03/2004
24	Hypoxia (Hypoxemia) 01/2024 - 02/2002
24	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 04/2013
16	Neoplasm Metastasis (Metastasis) 11/2023 - 02/2004
15	Breast Neoplasms (Breast Cancer) 01/2024 - 02/2004
15	Heart Failure 01/2024 - 04/2011
15	IGA Glomerulonephritis (IGA Nephropathy) 01/2024 - 04/2013
13	Cognitive Dysfunction 01/2024 - 10/2013
12	Hypertension (High Blood Pressure) 01/2024 - 04/2011
12	Proteinuria 01/2024 - 03/2015
11	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 01/2018
11	Inflammation (Inflammations) 05/2024 - 11/2014
11	Carcinogenesis 05/2024 - 05/2005
11	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 01/2003
11	Dementia (Dementias) 01/2023 - 01/2016
9	Insulin Resistance 01/2024 - 09/2005
9	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 10/2009
9	Myocardial Infarction 01/2023 - 04/2004
9	Carcinoma (Carcinomatosis) 05/2019 - 01/2013
8	Necrosis 12/2023 - 06/2011
8	Bone Resorption 07/2023 - 07/2009
8	Disease Progression 11/2021 - 02/2004
7	Fibrosis (Cirrhosis) 01/2024 - 04/2004
7	Glioma (Gliomas) 01/2024 - 04/2002
6	Atherosclerosis 05/2024 - 01/2020
6	Squamous Cell Carcinoma of Head and Neck 02/2024 - 06/2009
6	Arthritis (Polyarthritis) 01/2024 - 03/2004
6	Atrophy 01/2024 - 01/2015
6	Type 2 Diabetes Mellitus (MODY) 11/2023 - 04/2007
6	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 11/2003
6	Reperfusion Injury 07/2023 - 08/2009
5	Chronic Renal Insufficiency 01/2024 - 11/2019
5	Sepsis (Septicemia) 12/2023 - 02/2012
5	Thrombosis (Thrombus) 10/2023 - 03/2014
5	Non-alcoholic Fatty Liver Disease 01/2023 - 12/2018
5	Pain (Aches) 01/2023 - 01/2014
5	Obesity 01/2023 - 09/2005
5	Stomach Neoplasms (Stomach Cancer) 02/2021 - 06/2006
5	Acute Kidney Injury (Acute Renal Failure) 05/2016 - 07/2012
5	Leukemia 10/2013 - 01/2006
4	Hemorrhage 01/2024 - 06/2013
4	Body Weight (Weight, Body) 01/2024 - 04/2007
4	Genomic Instability 11/2023 - 01/2012
4	Ischemia 07/2023 - 08/2009
4	Osteoporosis 01/2023 - 11/2019
4	Colonic Neoplasms (Colon Cancer) 01/2023 - 05/2005
4	Familial Primary Pulmonary Hypertension 01/2023 - 01/2017

Drug/Important Bio-Agent (IBA)

54	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2004
21	Biomarkers (Surrogate Marker)IBA 09/2023 - 10/2009
15	CytokinesIBA 01/2024 - 10/2005
14	Transforming Growth Factor beta (TGF-beta)IBA 05/2011 - 04/2004
13	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2013
12	LipidsIBA 05/2024 - 09/2005
12	RNA (Ribonucleic Acid)IBA 04/2024 - 04/2005
12	CreatinineIBA 01/2024 - 08/2013
11	Oxygen (Dioxygen)IBA 04/2024 - 10/2002
11	Small Interfering RNA (siRNA)IBA 12/2022 - 05/2005
10	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 09/2005
10	VaccinesIBA 01/2023 - 04/2015
10	AntibodiesIBA 01/2023 - 12/2016
8	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 02/2002
8	Caspase 3 (Caspase-3)IBA 04/2023 - 03/2004
7	Long Noncoding RNAIBA 01/2024 - 01/2018
7	EnzymesIBA 12/2023 - 10/2003
7	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 11/2023 - 07/2013
7	Triglycerides (Triacylglycerol)IBA 01/2023 - 12/2018
7	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 02/2004
7	Arginine (L-Arginine)FDA Link 08/2022 - 07/2013
7	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 10/2009 - 02/2004
6	Interleukin-6 (Interleukin 6)IBA 05/2024 - 02/2008
6	Uric Acid (Urate)IBA 01/2024 - 11/2019
6	Amyloid (Amyloid Fibrils)IBA 01/2023 - 04/2013
6	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2022 - 05/2005
6	AcidsIBA 10/2021 - 04/2011
6	Metalloproteases (Metalloproteinases)IBA 01/2020 - 04/2005
5	Immunoglobulin A (IgA)IBA 01/2024 - 04/2013
5	salicylhydroxamic acid (SHAM)IBA 11/2023 - 04/2004
5	AlbuminsIBA 06/2023 - 01/2021
5	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2015
5	CateninsIBA 01/2023 - 08/2016
5	CollagenIBA 12/2022 - 01/2019
5	Adenosine Diphosphate (ADP)IBA 06/2021 - 03/2016
5	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2018
5	Messenger RNA (mRNA)IBA 01/2020 - 10/2013
5	Phosphotransferases (Kinase)IBA 11/2016 - 04/2006
5	UbiquitinIBA 07/2013 - 05/2005
4	Blood Glucose (Blood Sugar)IBA 01/2024 - 01/2019
4	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 01/2013
4	Immunoglobulin G (IgG)IBA 01/2023 - 09/2020
4	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 05/2005
4	S-AdenosylhomocysteineIBA 01/2023 - 01/2022
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022

Therapy/Procedure

55	Therapeutics 04/2024 - 03/2001
8	Drug Therapy (Chemotherapy) 01/2024 - 01/2006
5	Immunotherapy 12/2023 - 01/2022
5	Radiotherapy 11/2020 - 01/2018
4	Kidney Transplantation 10/2023 - 01/2021
4	Patient Readmission 01/2023 - 08/2013
4	Cognitive Training 01/2023 - 01/2016